Literature DB >> 20090360

Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults.

Srinivas Teppala1, Anoop Shankar, Jialiang Li, Tien Yin Wong, Alan Ducatman.   

Abstract

BACKGROUND/AIM: Serum gamma-glutamyltransferase (GGT), a biomarker of oxidative stress, is associated with an increased risk of diabetes and hypertension. However, it is not known whether higher serum GGT is independently associated with chronic kidney disease (CKD). Therefore, we examined the association between serum GGT levels and CKD in a representative sample of US adults.
METHODS: We conducted a cross-sectional study of 9,516 National Health and Nutrition Examination Survey 1999-2002 participants >or=18 years of age (52.40% women). Serum GGT was categorized into quartiles for the analysis. CKD (n = 622) was defined as an estimated glomerular filtration rate of <60 ml/min/1.73 m(2). RESULTS AND
CONCLUSION: Higher serum GGT levels were not associated with CKD after adjusting for age, sex, race/ethnicity, education levels, smoking, alcohol intake, body mass index (BMI), diabetes, hypertension and serum cholesterol. Compared to quartile 1 of GGT, the odds ratio (95% confidence interval) of CKD associated with quartile 4 was 1.02 (0.81-1.28); p trend = 0.377. Subgroup analyses that examined the relation between GGT and CKD by gender, alcohol intake, and BMI categories also showed a consistent null association. In summary, there was no association between increasing levels of serum GGT and CKD in a sample of US adults. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20090360     DOI: 10.1159/000274463

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  8 in total

1.  Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.

Authors:  Zhen-Wei Shen; Jie Xing; Qing-Lian Wang; Ali Faheem; Xiang Ji; Jie Li; Wei-Wei Bian; Zheng Jiang; Xiu-Jun Li; Fu-Zhong Xue; Jing Liu
Journal:  Int Urol Nephrol       Date:  2016-10-04       Impact factor: 2.370

2.  Evaluation of Homocysteine and Gamma-Glutamyl Transferase Concentrations As Markers of Chronic Kidney Disease: An Indian Perspective.

Authors:  Shyamkrishnan R; Gautom K Saharia; Sandip Panda; Manaswini Mangaraj
Journal:  Cureus       Date:  2022-03-08

3.  Serum Gamma-Glutamyl Transferase and Ferritin Synergistically Associated with the Rate of Chronic Kidney Disease.

Authors:  Tao Chen; Yan Ren; Yun Gao; Haoming Tian
Journal:  Dis Markers       Date:  2017-06-04       Impact factor: 3.434

4.  Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis.

Authors:  Aida Santaolalla; Hans Garmo; Anita Grigoriadis; Sundeep Ghuman; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mats Lambe; Lars Holmberg; Mieke Van Hemelrijck
Journal:  BMC Mol Cell Biol       Date:  2019-07-23

5.  Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population.

Authors:  Gabriele Nagel; Emanuel Zitt; Raphael Peter; Alfonso Pompella; Hans Concin; Karl Lhotta
Journal:  BMC Nephrol       Date:  2013-08-20       Impact factor: 2.388

6.  Elevated Serum Gamma-Glutamyltransferase (GGT) Activity and the Development of Chronic Kidney Disease (CKD) in Cigarette Smokers.

Authors:  Yuka Noborisaka; Masao Ishizaki; Michiko Yamazaki; Ryumon Honda; Yuichi Yamada
Journal:  Nephrourol Mon       Date:  2013-11-13

7.  Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease.

Authors:  Elizabeth B Somers; Daniel J O'Shannessy
Journal:  Biomark Insights       Date:  2014-05-25

Review 8.  Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk.

Authors:  Gerald Koenig; Stephanie Seneff
Journal:  Dis Markers       Date:  2015-10-12       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.